These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21965421)

  • 21. Intracortical inhibition abnormality during the remission phase of multiple sclerosis is related to upper limb dexterity and lesions.
    Nantes JC; Zhong J; Holmes SA; Whatley B; Narayanan S; Lapierre Y; Arnold DL; Koski L
    Clin Neurophysiol; 2016 Feb; 127(2):1503-1511. PubMed ID: 26394909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes.
    Rocca MA; Colombo B; Falini A; Ghezzi A; Martinelli V; Scotti G; Comi G; Filippi M
    Lancet Neurol; 2005 Oct; 4(10):618-26. PubMed ID: 16168930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
    Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
    Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
    Calabrese M; De Stefano N; Atzori M; Bernardi V; Mattisi I; Barachino L; Morra A; Rinaldi L; Romualdi C; Perini P; Battistin L; Gallo P
    Arch Neurol; 2007 Oct; 64(10):1416-22. PubMed ID: 17923625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients.
    Watanabe A; Matsushita T; Doi H; Matsuoka T; Shigeto H; Isobe N; Kawano Y; Tobimatsu S; Kira J
    J Neurol Sci; 2009 Jun; 281(1-2):34-40. PubMed ID: 19339021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
    Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Default-mode network dysfunction and cognitive impairment in progressive MS.
    Rocca MA; Valsasina P; Absinta M; Riccitelli G; Rodegher ME; Misci P; Rossi P; Falini A; Comi G; Filippi M
    Neurology; 2010 Apr; 74(16):1252-9. PubMed ID: 20404306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
    Farrar MA; Vucic S; Johnston HM; Kiernan MC
    Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
    Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multislice brain myelin water fractions at 3T in multiple sclerosis.
    Oh J; Han ET; Lee MC; Nelson SJ; Pelletier D
    J Neuroimaging; 2007 Apr; 17(2):156-63. PubMed ID: 17441837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.
    Rossi S; Mancino R; Bergami A; Mori F; Castelli M; De Chiara V; Studer V; Mataluni G; Sancesario G; Parisi V; Kusayanagi H; Bernardi G; Nucci C; Bernardini S; Martino G; Furlan R; Centonze D
    Mult Scler; 2011 Nov; 17(11):1301-12. PubMed ID: 21677024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S; Cheah BC; Kiernan MC
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of cortical excitability using threshold tracking techniques.
    Vucic S; Howells J; Trevillion L; Kiernan MC
    Muscle Nerve; 2006 Apr; 33(4):477-86. PubMed ID: 16315324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesions.
    Braley TJ; Lee YH; Mohan S; Segal BM; Berini S; Srinivasan A
    J Comput Assist Tomogr; 2012; 36(4):410-5. PubMed ID: 22805669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D
    Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
    Strasser-Fuchs S; Enzinger C; Ropele S; Wallner M; Fazekas F
    Mult Scler; 2008 Mar; 14(2):205-11. PubMed ID: 17986507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
    Anderson VM; Fisniku LK; Altmann DR; Thompson AJ; Miller DH
    Mult Scler; 2009 Jul; 15(7):811-7. PubMed ID: 19465449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.